Cargando…
An introductory review of post-resection chemotherapeutics for primary brain tumors
The treatment of central nervous system (CNS) tumors is complicated by high rates of recurrence and treatment resistance that contribute to high morbidity and mortality (Nat Rev Neurol. 2022;18:221–36. doi: 10.1038/s41582-022-00621-0). One of the challenges of treating these tumors is the limited pe...
Autores principales: | McGovern, Meaghan, Scanlon, Michaela, Stanton, Amanda, Lucke-Wold, Brandon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344890/ https://www.ncbi.nlm.nih.gov/pubmed/37455829 http://dx.doi.org/10.37349/etat.2023.00150 |
Ejemplares similares
-
Economic Trends in Commonly Used Drugs for Spinal Fusion and Brain Tumor Resection: An Analysis of the Medicare Part D Database
por: Doad, Jagroop, et al.
Publicado: (2023) -
Membranome Similarity between Glioblastoma Multiforme Cell Lines and Primary Tumors
por: Batchu, Sai, et al.
Publicado: (2023) -
“Timing of percutaneous endoscopic gastrostomy tube placement in post-stroke patients does not impact mortality, complications, or outcomes”: Commentary
por: Willman, Jonathan, et al.
Publicado: (2023) -
Endocrine resistant breast cancer: brain metastasis
por: Willman, Matthew, et al.
Publicado: (2022) -
Characterization and Treatment of Spinal Tumors
por: Amadasu, Efosa, et al.
Publicado: (2022)